Neogenomics Inc
NEO· Nasdaq
NEONeogenomics Inc
Filed Aug 5, 2016 · 10-Q · 36 days after period end · 0001564590-16-023004
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Net Income | $413.00K | -$176.00K | $274.00K | $273.00K |
| EPS Diluted | -$0.07 | $0.00 | $0.01 | $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 5, 2016 · 36 d after period end
